MedTrace Logo

Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults

NCT05449795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-01-17

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.

Conditions

Interventions

DEVICE

Device: Contour Next and Contour Plus Elite BGMS testing of arterial blood

The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.

Sponsors & Collaborators

  • Ascensia Diabetes Care

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-29
Primary Completion
2023-02-02
Completion
2023-04-20
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05449795 on ClinicalTrials.gov